AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01269762 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LipoCol Forte
Description: Single dose of one, two and four 600 mg red yeast rice capsules (LipoCol Forte) Multiple dose of 600 mg red yeast rice Capsules (LipoCol Forte)twice daily for 4.5 days
Study NCT02528370 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: telEPOC
Description: The program consisted of: 1) Educational program about COPD. This educational program was carried-out by a respiratory nurse in two 30-minute speeches to the patient and career, once at their inclusion in the program and again 1 year later. 2) Training in using the device (smart phone) that supported the telemonitoring. 3) Daily phone calls to make self-confident the patient during the first week. Afterwards the phone calls were established according to the capacity of the patient to manage on their own.
Study NCT04267770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin (circadian)
Description: Participant's own insulin adjusted to circadian infusion rates
Study NCT04267770 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Insulin (flat rate)
Description: Participant's own insulin set to flat basal rates
Study NCT00489814 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: Questionnaires administered within 3 weeks before the beginning of the radiation treatment course, twice during radiation therapy, and upon completion of radiation therapy.
Study NCT04037748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Puran T4®
Description: Participants who received a single oral dose of Puran T4® 600 mcg tablets (3 tablets of 200 mcg Levothyroxine sodium) in either Treatment Period 1 or 2 under fasting conditions.
Study NCT04037748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eutirox®
Description: Participants who received a single oral dose of Eutirox® 600 mcg tablets (3 tablets of 200 mcg Levothyroxine sodium) in either Treatment Period 1 or 2 under fasting conditions.
Study NCT04006496 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Expressive Writing Coaching
Description: For the intervention group, a trained expressive writing expert/coach will introduce the expressive writing concept to consented patients during the first visit, followed by an introduction of the first expressive writing exercise and prompt. The expert/coach will introduce new writing prompts at each subsequent visit. A script containing each visit's writing prompt and instructions will also be left with the patients for future use and/or reference. The trained clinician will collect, read, and analyze the writing sample using a health coaching technique by: 1) summarizing what the patient wrote, 2) evoking double-sided reflection by reading back the writing sample to the patient, and 3) developing a metaphor and review with the patient. Patients will also have the opportunity to ask the trained clinician questions and receive guidance.
Study NCT02951286 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: high pull headgear + OBA
Description: a modified version of the OBA (Open Bite Appliance),introduced by Erverdi and Usumez, will be applied in compination with a high pull headgear.
Study NCT02951286 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OBA (control group)
Description: A modified version of the OBA (Open Bite Appliance),introduced by Erverdi and Usumez, will be applied alone (Control group)
Study NCT03061175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Internet-Based Intervention
Description: Receive web-based CPM-DA
Study NCT03061175 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study NCT02301663 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Handgrip
Description: Subjects will be asked to squeeze and handgrip dynamometer to increase cardiac metabolic demand
Study NCT02301663 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Altitude simulation
Description: Subjects will breathe a lower concentration of oxygen to simulate the effects of altitude.
Study NCT02301663 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Leg exercise
Description: Subjects will perform leg exercise to increase metabolic demand.
Study NCT02613845 — intervention group
Intervention type: OTHER
Intervention: no intervention
Study NCT03271398 — intervention group
Intervention type: BEHAVIORAL
Intervention: EMDR
Description: Eye movement desensitization and reprocessing (intensive format)
Study NCT03271398 — intervention group
Intervention type: BEHAVIORAL
Intervention: PC
Description: Progressive counting (intensive format)
Study NCT04998838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tenofovir Disoproxil Fumarate 300 mg daily; HBV birth dose vaccine; hepatitis B immune globulin (HBIG)
Description: Antenatal screening for HBV, anti-viral treatment with tenofovir according to treatment eligibility criteria, and birth dose vaccination at delivery to prevent mother-to-child transmission of HBV
Study NCT04998838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regular Myanmar treatment
Description: Treated according to normal Myanmar processes for HBV positive patients
Study NCT04341220 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation is a noninvasive technique of neuronal modulation.
Study NCT04341220 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation is a noninvasive technique of neuronal modulation.
Study NCT04341220 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Balance exercises
Description: Specific balance exercises, focused on balance, postural control and control of the center of gravity within the support base.
Study NCT00826202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: D-serine
Description: 60 mg/kg/day
Study NCT00826202 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Inert Placebo
Study NCT00256997 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Risperidone long-acting injection (LAI)
Description: Risperidone LAI 25 milligram (mg), 37.5 mg or 50 mg intramuscular (injection of a substance into a muscle) injection will be administered every 2 weeks as per Investigator's discretion. An oral atypical antipsychotic will also be administered in the first 3 weeks following the dose increase. Duration of treatment will be 24 months.
Study NCT00256997 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral atypical Antipsychotic
Description: Oral atypical antipsychotic will be administered as per local label practice for 24 months. Participants will be switched to another atypical oral therapy as per Investigator's discretion.
Study NCT04341220 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Balance exercises
Description: Specific balance exercises, focused on balance, postural control and control of the center of gravity within the support base.
Study NCT03197857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity program : aquabike
Description: The aim of this project is to investigate in obese patients the changes induced by bariatric surgery on the various components of the physical condition and their postoperative evolution following an intervention combining a physical activity program (aquabike vs bicycle) with or without protein supplementation.
Study NCT03197857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity program : bicycle
Description: The aim of this project is to investigate in obese patients the changes induced by bariatric surgery on the various components of the physical condition and their postoperative evolution following an intervention combining a physical activity program (aquabike vs bicycle) with or without protein supplementation.
Study NCT03197857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity program : with protein supplementation
Description: The aim of this project is to investigate in obese patients the changes induced by bariatric surgery on the various components of the physical condition and their postoperative evolution following an intervention combining a physical activity program (aquabike vs bicycle) with or without protein supplementation
Study NCT03197857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity program : without protein supplementation
Description: The aim of this project is to investigate in obese patients the changes induced by bariatric surgery on the various components of the physical condition and their postoperative evolution following an intervention combining a physical activity program (aquabike vs bicycle) with or without protein supplementation
Study NCT01866384 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: mild induced hypothermia
Description: Patients with intraparancymal hemorrhage within 6 hours of onset will be randomized to either the mild induced hypothermia group or the normal temperature group (control). In this arm, the patient will have 72 hours of Targeted Temperature Managment to mild induced hypothermia (32-34 degrees Celcius).
Study NCT01866384 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Normal Temperature
Description: In this arm, the patient will have standard of care intraparenchymal hemorrhage management per institutional policy, with normal body temperature management (36-37 degrees Celcius).
Study NCT03451084 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASLAN003
Description: Patients will be administered with the study drug, ASLAN003. The study drug is to be administered orally, QD or BID. It is recommended to administer the study drug with food or within 30 minutes after food intake.
Study NCT00836043 — intervention group
Intervention type: DRUG
Intervention: Alemtuzumab (MabCampath)
Description: Intravenous therapy according to product information.
Study NCT02369107 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Verum acupuncture and medicine
Description: Participants will receive acupuncture therapy 1 hour prior to chemotherapy administration ，6 hours after chemotherapy administration，and once acupuncture therapy on the following day2,3,4,5. The stimulation points are RN12,LR13(bilaterally), RN6, ST25(bilaterally), PC6(bilaterally), ST36(bilaterally). The acupuncture needle in ST36 and auxiliary point will be connected to form a circuit containing a SDZ-V stimulator for 30 min with a frequency of 2/100 Hz. They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).
Study NCT02369107 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham acupuncture and medicine
Description: Participants will receive minimal acupuncture therapy at the same time as the intervention group .The stimulation points are not belong to traditional Chinese medicine.They will receive 8mg Ondansetron Intravenously twice a day during the chemotherapy administration period (5 days in total).
Study NCT03221738 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: App-Based Cognitive Behavioral Therapy
Description: 12-week Smartphone delivered CBT for BDD. In-person cognitive behavioral therapy (CBT) is an empirically supported treatment for BDD. The app-delivered CBT in this project includes modules such as cognitive skills (e.g., cognitive restructuring, core belief work), behavioral skills (e.g., exposure with ritual prevention), and perceptual retraining/mindfulness skills.
Study NCT02820155 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGN1016
Description: Stage I: single oral dose Stage II: multiple oral dose (QD, 7days)
Study NCT02820155 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Stage I: single oral dose Stage II: multiple oral dose (QD, 7days)
Study NCT01850485 — intervention group
Intervention type: DEVICE
Intervention: microcirculation by SDF and NIRS, in 33 and 36 degrees
Description: at baseline, after 12 and 24 hours in both arms
Study NCT00077363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tipifarnib
Description: Given PO
Study NCT00077363 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: capecitabine
Description: Given PO
Study NCT02240979 — intervention group
Intervention type: DEVICE
Intervention: cardiac MRI
Description: cardiac MRI
Study NCT03280875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pedalling exercises
Description: pedalling exercises on a bicycle ergometer
Study NCT01301950 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Custom Patient Instrumentation
Description: TruMatch® Personalized Solutions is the brand name of DePuy Orthopaedics, Inc. custom patient instrumentation (CPI). TruMatch™ is a pair of custom-made cutting blocks that allow distal femoral and proximal tibial cuts to be made according to a predefined surgical plan. The inner surface of the femoral block is manufactured to match the geometry of the patient's distal femur. The inner surface of the tibial block is manufactured to match the patient's proximal tibia. The geometric data is obtained from a CT scan and a preoperative plan approved by the surgeon
Study NCT01301950 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Instruments
Description: Total Knee Arthroplasty implanted using conventional instruments (non-CPI) and surgical technique.
Study NCT04144374 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Omadacycline
Description: Omadacycline will be administered 200 mg IV once daily on day 1 followed by omadacycline 300 mg by mouth once daily for 2-4 doses.
Study NCT04144374 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Omadacycline
Description: Omadacycline will be administered 200 mg IV once daily on day 1 followed by omadacycline 300 mg by mouth once daily for 2-4 doses.
Study NCT04144374 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microdialysis Catheter Insertion
Description: A 20 kilodalton microdialysis probe (63 MD catheter; MDialysis Inc., N. Chelmsford, MA) will be inserted into the subcutaneous tissue at the margin of the wound (patient group) or in the thigh tissue (healthy volunteers). The probe will be left in place for the final dose and all tissue sampling procedures thereafter. This probe is perfused with a physiologic solution to collect interstitial fluid samples. The probe will then be removed after completion of sample collection.
Study NCT04144374 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microdialysis Catheter Insertion
Description: A 20 kilodalton microdialysis probe (63 MD catheter; MDialysis Inc., N. Chelmsford, MA) will be inserted into the subcutaneous tissue at the margin of the wound (patient group) or in the thigh tissue (healthy volunteers). The probe will be left in place for the final dose and all tissue sampling procedures thereafter. This probe is perfused with a physiologic solution to collect interstitial fluid samples. The probe will then be removed after completion of sample collection.
Study NCT03536975 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Platform
Description: The groups will be comprised of one intervention group with access to the web platform CAREGIVERSPRO-MMD and another control group without any access to it
Study NCT04001075 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TJ107
Description: Patients enrolled in dose escalation part will be given 2 doses (28 days/dose) during the main-treatment period
Study NCT02491957 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: LOFT Therapy
Description: LOFT Therapy™ will be performed 2 times a week for 4 weeks a total of 8 sessions. The patient will be wrapped with fabric cuffs, on up to four limbs. The cuffs are applied to the widest part of the biceps and upper thighs at pressures between 80-100 mmHg with minimal venous encroachment. The patients will ride a recumbent bike for 18 total minutes of sub-maximal exertion (up to 70% repetition maximum ), with the option of up to 2 periods of 15-second higher intensity exertions as tolerated, followed by individualized respiratory recovery periods determined by the relative decrease in breathing effort.~The 18-minute session will be preceded by a two-minute compression check, where the wraps will be adjusted based on any signs or symptoms of nerve or vessel impingement.
Study NCT04077450 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Heart-Focused Breathing Intervention
Description: Participants will receive an online standardized HeartMath© heart-focused breathing intervention.
Study NCT06476522 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy Program
Description: In the first evaluation, 5 different exercises were shown and the patients were asked to do home exercises in accordance with the given program. The physiotherapist suggested starting with a 10-minute walk 5 times a week and then gradually increasing the walking time. The patients were given a program for balance and sensory training. They were asked to apply the physiotherapy program at least 3 days a week for 12 weeks. Weekly follow-up of the patients was carried out by the physiotherapist over the phone or face to face when they underwent routine treatment.
Study NCT06476522 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: To Inform
Description: The patients were informed that they would be evaluated by the physiotherapist when they came to the routine doctor's control in the first week and at the end of the 12 weeks. At the end of 12 weeks, these patients were also given home-based exercise program advice.
Study NCT06476522 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: To Inform
Description: The patients were informed that they would be evaluated by the physiotherapist when they came to the routine doctor's control in the first week and at the end of the 12 weeks. At the end of 12 weeks, these patients were also given home-based exercise program advice.
Study NCT03786562 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Intrathecal Morphine
Description: Group 1
Study NCT03786562 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intrathecal Morphine + Intravenous Nalbuphine
Description: Group 2
Study NCT04502004 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: App for health=mhealth
Description: Cognitive-Behavioural Therapy and Clinical Practice Guide that recommends 5 Aes: Ask about tobacco, Advise smoking cessation, Assess tobacco consumption, Assist and Arrange (Fiore et alt., 2008)
Study NCT02048618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GLPG0634
Description: 100 mg oral tablet, intake once daily for 20 weeks
Study NCT02048618 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: placebo oral tablets, intake once daily for 20 weeks
Study NCT02048618 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo oral tablets, intake once daily for 20 weeks
Study NCT04377711 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ciclesonide
Description: 160mcg Inhaler
Study NCT04377711 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching Placebo Inhaler
Study NCT01918423 — intervention group
Intervention type: BEHAVIORAL
Intervention: Lifestyle intervention during pregnancy
Description: Energy requirements for each participants´ mother were individually estimated according to weight and level of activity during pregnancy. Women in the active intervention group were encouraged to be moderately physically active 30-60 minutes a day.Women in this group also had free full time membership in a fitness center for six months. In the fitness centers they had closed training classes with trained physiotherapists for one hour each week.
Study NCT02607683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XAF5 (concentration A: 0.1%)
Study NCT02607683 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XAF5 (concentration B: 0.035%)
Study NCT02607683 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Matching placebo
Study NCT00555477 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: anastrozole
Description: 1 mg tablet by mouth once a day
Study NCT04275505 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: shortwave diathermy treatment
Description: shortwave diathermy is a deep heating physical therapy agent. It was found efficiaous in carpal tunnel syndrome which is an entrapment neuropathy like ulnar nerve entrapment so it was hypothesised that shortwave diathermy could be an effective treatment method in ulnar nerve entrapment.
Study NCT04275505 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo shortwave diathermy treatment
Description: shortwave device was not turned on while participants were asked to put their elbow into the device
Study NCT01146704 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass
Description: Standard protein diet as control, based on 0.5 gram protein per pound of lean body mass, isocaloric (same number of calories) and consisting of 15% protein and 55% carbohydrate.
Study NCT01146704 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Protein powder supplement, High Level Protein, based on 1 gram of protein per pound of lean body mass: 25% protein and 45% carbohydrate
Description: High level of protein diet, based on 1 gram of protein per pound of subject's lean body mass, isocaloric (same number of calories) and consisting of 30% protein and 40% carbohydrate.
Study NCT03857204 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SAMPL plain wave algorithm
Description: SAMPL's plain-wave algorithm allowing portable US or Wireless Probe scanning - thus enabling clinicians with more flexible point-of-care locations when performing US scans for fetal weight assessment.